Business Description
Founded in 1995 and headquartered in Dijon, France, Oncodesign Precision Medicine is a biopharmaceutical company developing targeted therapies for serious diseases including cancer, inflammatory bowel disease, and Parkinson's disease. Its lead drug candidates work by blocking specific proteins linked to disease progression, while a separate line of research focuses on molecules that can both detect and treat advanced digestive and pancreatic cancers in a single approach.
